HealthQuill
Health Research

WSU study reveals how endometriosis rewires the brain to amplify chronic pain

Swati Sri A Washington State University (WSU) study has uncovered the biological mechanism behind one of the most frustrating aspects of endometriosis: why.

Read More
Diabetes
Health

Newly recognized Type-5 diabetes may be affecting 25 million people worldwide

Swati Sri April 15, 2026: The International Diabetes Federation (IDF) has officially recognized a distinct fifth type of diabetes known as Type 5.

Read More
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Drugs Health Pharma

Novartis AG to acquire Exellergy for $2 billion, expand allergy portfolio

Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.

Read More
Uncategorized

Genetic study finds how Kenya’s Turkana survive with almost no water

HQ Staff writer March 26, 2026: Deep in the sun-scorched lands of northern Kenya, where temperatures soar and water sources vanish for months.

Read More
Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a type of blood cancer, according to a statement.
Drugs Health Pharma

Merck to buy Terns for $6.7 billion as Keytruda drug patent loss looms

Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a.

Read More
Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing average blood sugar levels by up to 2.16% in diabetic patients and trimmed weight by almost 10%, according to a statement.
Drugs Health Pharma

Novo, United’s trial drug cuts sugar levels by 2.16%, weight loss of 9.8%

HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing.

Read More
Pfizer Inc. and France-based Valneva SE's investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals aged five and above.
Drugs Medical Pharma

Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy

HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals.

Read More
Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for $2 billion, according to a statement. 
Drugs Medical Pharma

Gilead Sciences to acquire US-based Ouro Medicines for up to $2 billion 

Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for.

Read More
Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for a deal worth $3 billion.
Drugs Medical Pharma

Novartis AG to buy experimental oral drug of Pikavation for $3 billion

Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for.

Read More
Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.
Health Medical Pharma

Roche expands artificial intelligence deployment in pact with Nvidia

Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.

Read More